RAK Diabetes Challenge 2025 Encourages Natural Diabetes Reversal; Top Winners to Receive AED 20,000 in Prizes. Ras Al Khaimah, UAE – August 22, 2025 One of the UAE’s most impactful public health movements is back. RAK Hospital, in collaboration Read More
In ATTAIN-1, the investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies at 72 weeks. Orforglipron achieved the primary and all key secondary endpoints, including demonstrating improvements Read More
Dubai, UAE, 15 August 2025 As children across the UAE return to classrooms this month, Barraquer Eye Hospital UAE is urging parents and educators to take a closer look, literally, at the impact of screens on young Read More
Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05. Progression-free survival data was immature, but trending in favor of pirtobrutinib. BRUIN CLL-314 is the first-ever head-to-head Read More
India, 11th August 2025 Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™. The capital Read More
